DE SB292

Expands the Opioid Antagonist Access Program to authorize public safety personnel and members of the public to receive, carry, and administer opioid antagonists (naloxone and FDA-approved alternatives) to individuals experiencing known or suspected opioid overdose.

Requires the Department of Health and Social Services to create written treatment protocols and standing orders for opioid antagonist administration, approved by the State EMS Medical Director or Division of Public Health leadership.

Establishes immunity from civil liability, criminal liability, and professional disciplinary action for health-care practitioners, pharmacists, public safety personnel, and lay individuals who administer opioid antagonists in good faith, unless injuries or death result from willful, wanton, reckless, or grossly negligent conduct.

Clarifies that possession and use of opioid antagonists under the program does not violate controlled substances laws or constitute unlawful practice of medicine.

Mandates that individuals must complete Department-approved training programs before receiving, carrying, and administering opioid antagonists; does not require agencies to mandate that personnel carry or administer the drugs.